# US 5,702,891 A · HAV probes for use in solution phase sandwich hybridization and assays for detecting the presence of HAV

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 5,702,891 A
- Document ID: US5702891A
- Status: Granted
- Kind: A
- Application number: 08/417,476
- Filed: 1995-04-05
- Granted: 1997-12-30
- Earliest claimed: 1991-12-23
- Assignees: Chiron Corporation
- Inventors: Janice A. Kolberg; Michael S. Urdea
- Web page: https://patentgrep.com/patent/US5702891A

## CPC

- C12Q 1/706: {for hepatitis}
- C12Q 1/682: Signal amplification
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Novel DNA probe sequences for detection of HAV in a sample in a solution phase sandwich hybridization assay are described. Amplified nucleic acid hybridization assays using the probes are exemplified.

## Claims

### Claim 1

A synthetic oligonucleotide useful as an amplifier probe in a sandwich hybridization assay for HAV (Hepatitis A Virus), wherein said oligonucleotide consists of:
a first segment having a minimum length of 25 nucleotides and a maximum length of 100 nucleotides which segment is at least 90% homologous to a segment of HAV nucleic acid, wherein said first segment comprises a nucleotide sequence selected from the group consisting of SEQ ID NOS: 6-27; and
a second segment consisting of a nucleotide sequence which is at least 90% homologous to an oligonucleotide segment of a nucleic acid multimer wherein said second segment is not complementary to HAV nucleic acid;
and optionally one or more noncomplementary segments each consisting of a nucleotide sequence that is not complementary to HAV nucleic acid.

### Claim 2 (depends on 1)

The synthetic oligonucleotide of claim 1, wherein said second segment comprises SEQ ID NO:38.

### Claim 3 (depends on 1)

The synthetic oligonucleotide of claim 1, wherein said first segment consists of a nucleotide sequence selected from the group consisting of SEQ ID NOS: 6-27.

### Claim 4

A synthetic oligonucleotide useful as a capture probe in a sandwich hybridization assay for HAV, wherein the synthetic oligonucleotide consists of:
a first segment having a minimum length of 25 nucleotides and a maximum length of 100 nucleotides which segment is at least 90% homologous to a segment of HAV nucleic acid, wherein said first segment comprises a nucleotide sequence selected from the group consisting of SEQ ID NOS; 28-37; and
a second segment consisting of a nucleotide sequence which is at least 90% homologous to an oligonucleotide bound to a solid phase wherein said second segment is not complementary to HAV nucleic acid;
and optionally one or more noncomplementary segments each consisting of a nucleotide sequence that is not complementary to HAV nucleic acid.

### Claim 5 (depends on 4)

The synthetic oligonucleotide of claim 4, wherein said second segment comprises SEQ ID NO:39.

### Claim 6 (depends on 4)

The synthetic oligonucleotide of claim 4, wherein said first segment consists of a nucleotide sequence selected from the group consisting of SEQ ID NOS: 28-37.

### Claim 7

A set of synthetic oligonucleotides useful as amplifier probes in a sandwich hybridization assay for HAV, comprising at least two different oligonucleotide probes, wherein each oligonucleotide probe consists of:
a first segment having a minimum length of 25 nucleotides and a maximum length of 100 nucleotides which segment is at least 90% homologous to a segment of HAV nucleic acid, wherein said first segment comprises a nucleotide sequence selected from the group consisting of SEQ ID NOS: 6-27; and
a second segment consisting of a nucleotide sequence which is at least 90% homologous to an oligonucleotide segment of a nucleic acid multimer wherein said second segment is not complementary to HAV nucleic acid;
and optionally one or more noncomplementary segments each consisting of a nucleotide sequence that is not complementary to HAV nucleic acid.

### Claim 8 (depends on 7)

The set of synthetic oligonucleotides of claim 7, wherein each said second segment comprises SEQ ID NO:38.

### Claim 9 (depends on 7)

The set of synthetic oligonucleotides of claim 7, wherein said set comprises at least five different oligonucleotide probes.

### Claim 10 (depends on 7)

The set of synthetic oligonucleotides of claim 7, wherein each of said first segments consists of a nucleotide sequence selected from the group consisting of SEQ ID NOS: 6-27.

### Claim 11

A set of synthetic oligonucleotides useful as capture probes in a sandwich hybridization assay for HAV, comprising at least two different oligonucleotide probes, wherein each oligonucleotide probe consists of:
a first segment having a minimum length of 25 nucleotides and a maximum length of 100 nucleotides which segment is at least 90% homologous to a segment of HAV nucleic acid, wherein said first segment comprises a nucleotide sequence selected from the group consisting of SEQ ID NOS: 28-37; and
a second segment consisting of a nucleotide sequence which is at least 90% homologous to an oligonucleotide bound to a solid phase wherein said second segment is not complementary to HAV nucleic acid;
and optionally one or more noncomplementary segments each consisting of a nucleotide sequence that is not complementary to HAV nucleic acid.

### Claim 12 (depends on 11)

The set of synthetic oligonucleotides of claim 11, wherein each said second segment comprises SEQ ID NO:39.

### Claim 13 (depends on 11)

The set of synthetic oligonucleotides of claim 11, wherein said set comprises at least five different oligonucleotide probes.

### Claim 14 (depends on 11)

The set of synthetic oligonucleotides of claim 11, wherein each of said first segments consists of a nucleotide sequence selected from the group consisting of SEQ ID NOS: 28-37.

### Claim 15 (depends on 7)

A solution sandwich hybridization assay for detecting the presence of HAV in a sample, comprising
(a) contacting the sample with (i) amplifier probes comprising the set of synthetic oligonucleotides of claim 7 and (ii) a set of capture probe oligonucleotides wherein there is a molar excess of amplifier probes and of capture probes over analyte nucleic acid in the sample, wherein said set of capture probe oligonucleotides comprises at least two different oligonucleotides each of which consists of
a first segment having a minimum length of 25 nucleotides and a maximum length of 100 nucleotides which segment is at least 90% homologous to a segment of HAV nucleic acid, wherein said first segment comprises a nucleotide sequence selected from the group consisting of SEQ ID NOS: 28-37; and
a second segment consisting of a nucleotide sequence which is at least 90% homologous to an oligonucleotide bound to a solid phase wherein said second segment is not complementary to HAV nucleic acid;
and optionally one or more noncomplementary segments each consisting of a nucleotide sequence that is not complementary to HAV nucleic acid;
(b) contacting the product of step (a) with said oligonucleotide bound to the solid phase;
(c) thereafter separating materials not bound to the solid phase;
(d) contacting the bound product of step (c) with a nucleic acid multimer, said multimer comprising at least one oligonucleotide segment that is at least 90% homologous to the second segment of the amplifier probe polynucleotide and a multiplicity of second oligonucleotide segments that are at least 90% homologous to a labeled oligonucleotide;
(e) removing unbound multimer;
(f) contacting the solid phase complex product of step (e) with the labeled oligonucleotide;
(g) removing unbound labeled oligonucleotide; and
(h) detecting the presence of label in the solid phase complex product of step (g) and, thereby, detecting the presence of virus in the sample.

### Claim 16 (depends on 15)

The assay of claim 15, wherein said set of amplifier probes comprises at least five different oligonucleotide probes.

### Claim 17 (depends on 15)

The assay of claim 15, wherein said set of capture probes comprises at least five different oligonucleotide probes.

### Claim 18 (depends on 7)

A kit for the detection of HAV in a sample comprising in combination
(i) a set of amplifier probe oligonucleotides comprising the set of oligonucleotides of claim 7;
(ii) a set of capture probe oligonucleotides comprising at least two different oligonucleotides each of which consists of
a first segment having a minimum length of 25 nucleotides and a maximum length of 100 nucleotides which segment is at least 90% homologous to a segment of HAY nucleic acid, wherein said first segment comprises a nucleotide sequence selected from the group consisting of SEQ ID NOS: 28-37; and
a second segment consisting of a nucleotide sequence which is at least 90% homologous to an oligonucleotide bound to a solid phase wherein said second segment is not complementary to HAV nucleic acid;
and optionally one or more noncomplementary segments each consisting of a nucleotide sequence that is not complementary to HAV nucleic acid;
(iii) a nucleic acid multimer, said multimer comprising at least one oligonucleotide segment that is at least 90% homologous to the second segment of the amplifier probe polynucleotide and a multiplicity of second oligonucleotide segments that are at least 90% homologous to a labeled oligonucleotide; and
(iv) a labeled oligonucleotide.

### Claim 19 (depends on 18)

The kit of claim 18, wherein said set of amplifier probes comprises at least five different oligonucleotide probes.

### Claim 20 (depends on 18)

The kit of claim 18, wherein said set of capture probes comprises at least five different oligonucleotide probes.